Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (781-790 of 1,011) with videos related to

Pageof 102
Sort By:
Plos One|March 29, 2013
Pharmacometabolomics reveals racial differences in response to atenolol treatmentWilliam R Wikoff, Reginald F Frye, Hongjie Zhu, et al.
Cancer|April 28, 2006
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanomaWen-Jen Hwu, Katherine S Panageas, Jennifer H Menell, et al.
Kidney International Reports|November 17, 2017
Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical TrialMaria V Irazabal, Jaime D Blais, Ronald D Perrone, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 16, 2019
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney DiseaseKyongtae T Bae, Wen Zhou, Chengli Shen, et al.
Oncotarget|December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutationParisa Momtaz, James J Harding, Charlotte Ariyan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2016
Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney DiseaseYoungwoo Kim, Yinghui Ge, Cheng Tao, et al.
Nature Methods|December 22, 2022
Multiplexed transcriptome discovery of RNA-binding protein binding sites by antibody-barcode eCLIPDaniel A Lorenz, Hsuan-Lin Her, Kylie A Shen, et al.
American Journal of Hypertension|July 27, 2013
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertensionArlene B Chapman, George Cotsonis, Vishal Parekh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 13, 2026
Relationship between Total Kidney Volume and Estimated Glomerular Filtration Rate in Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Chelsie Parker, Lilian Golzarri-Arroyo, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2006
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohortAndrew D Rule, Vicente E Torres, Arlene B Chapman, et al.
Pageof 102

Showing results (781-790 of 1,011) with videos related to

Sort By:
Pageof 102
Plos One|March 29, 2013
Pharmacometabolomics reveals racial differences in response to atenolol treatmentWilliam R Wikoff, Reginald F Frye, Hongjie Zhu, et al.
Cancer|April 28, 2006
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanomaWen-Jen Hwu, Katherine S Panageas, Jennifer H Menell, et al.
Kidney International Reports|November 17, 2017
Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical TrialMaria V Irazabal, Jaime D Blais, Ronald D Perrone, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 16, 2019
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney DiseaseKyongtae T Bae, Wen Zhou, Chengli Shen, et al.
Oncotarget|December 30, 2017
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutationParisa Momtaz, James J Harding, Charlotte Ariyan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2016
Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney DiseaseYoungwoo Kim, Yinghui Ge, Cheng Tao, et al.
Nature Methods|December 22, 2022
Multiplexed transcriptome discovery of RNA-binding protein binding sites by antibody-barcode eCLIPDaniel A Lorenz, Hsuan-Lin Her, Kylie A Shen, et al.
American Journal of Hypertension|July 27, 2013
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertensionArlene B Chapman, George Cotsonis, Vishal Parekh, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 13, 2026
Relationship between Total Kidney Volume and Estimated Glomerular Filtration Rate in Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Chelsie Parker, Lilian Golzarri-Arroyo, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2006
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohortAndrew D Rule, Vicente E Torres, Arlene B Chapman, et al.
Pageof 102